| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 30,494 | 39,849 | 42,889 | 68,777 | | Selling General and Administrative | 12,273 | 13,537 | 14,917 | 12,978 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (42,767) | (53,386) | (57,806) | (81,755) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 159 | 309 | 102 | 216 | | Earnings Before Interest And Taxes | (42,608) | (53,077) | (57,704) | (81,539) | | Interest Expense | 2,947 | 2,527 | 1,708 | 1,754 | | Income Before Tax | (45,555) | (55,604) | (59,412) | (83,293) | | Income Tax Expense |
-
|
-
|
-
| 2 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (45,555) | (55,604) | (59,412) | (83,295) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (45,555) | (55,604) | (59,412) | (83,295) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($45,555) | ($55,604) | ($59,412) | ($83,295) |
|
0.11% Nasdaq 
0.01%
Income Statement
